S-ET01. Emerging Therapeutics Summit: Device Technology Roundtable - Innovations in CIEDs
Co-Chairs: Jeanne E.. Poole, MD, FHRS, CCDS. Univ of Washington School of Medicine, Seattle, WA and Ulrika Maria. Birgersdotter-Green, MD, FHRS. UC San Diego Health Systems, La Jolla, CA
The first session will involve a Case Based Round Table Discussion involving illustrative cases reflecting current challenges and future opportunities in device-based technology a panel of leading experts at the cutting edge of innovation, research, and development. Topics to be discussed include next generations leadless and lead technology, advances in His bundle and LV endocardial pacing, cardiac contractility, evolutions in subcutaneous ICD technology, wearable external defibrillation, and technological advancements in external monitoring and resuscitation.
S-ET02. Emerging Therapeutics Summit: Developing Chamber-Specific Myocardial Preparations for Drug and Disease Testing
Co-chairs: Mark E.. Anderson, MD, FHRS. Johns Hopkins University Dept Of Medicine, Baltimore, MD, and L. Lee Eckhardt, MD, FHRS. University of Wisconsin, Schoo, Madison, WI
This session will feature state-of-the art futuristic talks by leading experts who are at the cutting edge of research and development of novel biologic and pharmacologic approaches for the treatment of heart rhythm disorders, which have the potential to disrupt traditional device- and ablation- based approaches to treatment of arrhythmias.
S-ET03. Emerging Therapeutics Summit: Ablation Part I - Future of Arrhythmia Mapping
Co-chairs:Jonathan M.. Kalman, MBBS, PhD, FHRS. Royal Melbourne Hospital, Australia and Isabel Deisenhofer, MD. German Heart Center Munich Dep, Munich, Germany
This session will feature state-of-the art talks by leading experts who are at the cutting edge of research and innovation in the field of arrhythmia and substrate mapping on advances that will have a major impact on future ablation strategies and risk stratification approaches. Each lecture will be followed by an opportunity for questions from the audience.
S-ET04. Emerging Therapeutics Summit: Ablation Part II - Technologic Ablative Therapy
Co-chairs: David J.. Callans, MD, FHRS, CCDS. Hospital of the Univ of Pennsylvania, Washington Crossing, PA and Kyoko Soejima, MD. Kyorin University School of Medicine, Japan
This session will feature state-of-the art talks by experts who are at the forefront of innovation and advances in ablation technology that will transform the field over the next 5-years. These leading experts will then participate in a panel discussion with interaction from the audience on the future of ablation for cardiac arrhythmias.